US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 11.970
  • +1.150+10.63%
Close Aug 14 16:00 ET
533.50MMarket Cap-21375P/E (TTM)

Y-mAbs Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Y-mAbs Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Aug 12, 2024

Revenue(YoY)

22.80M

+9.86%
EPS(YoY)

-0.21

-50.00%
Analyst Rating

Buy

Aug 14, 2024

Y-mAbs Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 25.338M--
--2024/Q3-- / 23.890M--
Aug 12, 20242024/Q222.798M / 23.019M--
May 7, 20242024/Q119.931M / 22.220M--
Feb 29, 20242023/Q423.363M / 20.954M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 25.338M--
--2024/Q3-- / 23.890M--
Aug 12, 20242024/Q222.798M / 23.019M--
May 7, 20242024/Q119.931M / 22.220M--
Feb 29, 20242023/Q423.363M / 20.954M--

Unlock Free Earnings Estimates

Y-mAbs Therapeutics Earnings Reports

  • Y-mAbs Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 07:10 ET

  • Y-mAbs Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 16:22 ET

  • Y-mAbs Therapeutics | 10-K: FY2023 Annual Report

    Feb 29 22:38 ET

  • Y-mAbs Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 13, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 14, 2024

    Buy

    • Buy

      83.33%

    • Hold

      0.00%

    • Sell

      16.67%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg